Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

Range Cancer Therapeutics Index ETF (CNCR)

9.00
-0.43
(-4.56%)
At close: 4:00:00 PM EDT
9.00
-0.05
(-0.50%)
After hours: 4:05:12 PM EDT
Loading Chart for CNCR
  • Previous Close 9.43
  • Open 9.41
  • Bid 9.00 x 500
  • Ask 9.11 x 500
  • Day's Range 9.00 - 9.41
  • 52 Week Range 9.00 - 16.27
  • Volume 5,824
  • Avg. Volume 2,765
  • Net Assets 8.93M
  • NAV 9.42
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -23.40%
  • Beta (5Y Monthly) 0.92
  • Expense Ratio (net) 0.79%

The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.

Range Cancer

Fund Family

Health

Fund Category

8.93M

Net Assets

2015-10-13

Inception Date

Performance Overview: CNCR

View More

Trailing returns as of 3/31/2025. Category is Health.

YTD Return

CNCR
23.40%
Category
3.82%
 

1-Year Return

CNCR
43.26%
Category
0.19%
 

3-Year Return

CNCR
19.39%
Category
1.56%
 

People Also Watch

Holdings: CNCR

View More

Sector Weightings

SectorCNCR
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: CNCR

View More

Research Reports: CNCR

View More

Related Tickers